GlaxoSmithKline: Colitis, Ulcerative trials
The registry lists 16 Colitis, Ulcerative studies with GlaxoSmithKline as lead sponsor. 2 are open to participants now and 5 have results posted.
Phase 1 10Phase 2 5No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative ColitisRecruitingNCT07747480Phase 1
- A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative ColitisRecruitingNCT07747467Phase 1
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy ParticipantsCompletedNCT05131971Phase 1Results posted
- Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative ColitisTerminatedNCT03893565Phase 2Results posted
- GSK2982772 Study in Subjects With Ulcerative ColitisCompletedNCT02903966Phase 2Results posted
- Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative ColitisCompletedNCT01036022Phase 2Results posted
- Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative ColitisTerminatedNCT00748410Phase 2Results posted
- A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy ParticipantsActive, not recruitingNCT06681181Phase 1
- Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple IndicationsCompletedNCT06488703
- A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy ParticipantsWithdrawnNCT05999708Phase 1
- Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.TerminatedNCT02000453Phase 1
- Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002CompletedNCT01984047Phase 1
- A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative ColitisWithdrawnNCT01658605Phase 2
- A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative ColitisCompletedNCT01453491Phase 1
- Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative ColitisWithdrawnNCT01434576Phase 1
- GI-270384 Study In Patients With Mild To Moderate Ulcerative ColitisTerminatedNCT00457171Phase 1